Gary Goodman
Gary E. Goodman, M.D.

Gary E. Goodman, M.D.

Gary E. Goodman, M.D.
Specialty

Oncology - Medical, Oncology - Medical: Swedish Cancer Institute

Clinical Interests / Special Procedures Performed

Head and Neck Oncology, Melanoma

  • Accepting Children: No
  • Accepting New Patients: Yes
  • Accepting Medicare: Yes
  • Accepting Medicaid/DSHS: Yes
Payment Methods Accepted:

Medicare, Medicaid/DSHS, Bill Insurance, VISA, Master Card, Cash, Check, American Express, Discover Card

Insurance Accepted:

Contact this office for accepted insurance plans.

Additional Information:

Internship: University of Oregon, OR


APPOINTMENTS AND POSITIONS:

2001 – present   Joint Member, Fred Hutchinson Cancer Research Center
1997 – present   Principal Investigator, Carotene And Retinol Efficacy Trial (CARET), Fred Hutchinson Cancer Research Center
1996-Present   Southwest Oncology Group Chairman, Cancer Chemoprevention Subcommittee
1984-Present   Clinical Assistant Professor of Environmental Health, University of Washington
1983-Present   Affiliate Investigator, Public Health Sciences, Fred Hutchinson Cancer Research Center
1982-Present   University of Washington
1982-Present   Affiliate Investigator, Medical Oncology, Fred Hutchinson Cancer Research Center
1981-Present   Swedish Medical Center Cancer Institute

Medical School

University of Illinois , IL; University of Oregon, OR

Residency

University of Oregon, OR

Fellowship(s)

University of Arizona Health Sciences Center, AZ - Hematology/Oncology

Board Certifications

Oncology

Additional Information:

Internship: University of Oregon, OR


APPOINTMENTS AND POSITIONS:

2001 – present   Joint Member, Fred Hutchinson Cancer Research Center
1997 – present   Principal Investigator, Carotene And Retinol Efficacy Trial (CARET), Fred Hutchinson Cancer Research Center
1996-Present   Southwest Oncology Group Chairman, Cancer Chemoprevention Subcommittee
1984-Present   Clinical Assistant Professor of Environmental Health, University of Washington
1983-Present   Affiliate Investigator, Public Health Sciences, Fred Hutchinson Cancer Research Center
1982-Present   University of Washington
1982-Present   Affiliate Investigator, Medical Oncology, Fred Hutchinson Cancer Research Center
1981-Present   Swedish Medical Center Cancer Institute

PUBLICATIONS:

Cheng TY, Goodman GE, Thornquist MD, Barnett MJ, Beresford SA, Lacroix AZ, Zheng Y, Neuhouser ML. Estimated intake of vitamin D and its interaction with vitamin A on lung cancer risk among smokers. Int J Cancer. 2014 Mar 13.
 
Cheng TY, Millen AE, Wactawski-Wende J, Beresford SA, Lacroix AZ, Zheng Y, Goodman GE, Thornquist MD, Neuhouser ML. Vitamin D Intake Determines Vitamin D Status of Postmenopausal Women, Particularly Those with Limited Sun Exposure. J Nutr. 2014 Mar 5.
 
Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Lippman SM, Klein EA. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst. 2014 Mar 1;106(3)
 
Sin DD, Tammemagi CM, Lam S, Barnett MJ, Duan X, Tam A, Auman H, Feng Z, Goodman GE, Hanash S, Taguchi A. Pro-surfactant protein B as a biomarker for lung cancer prediction.
J Clin Oncol. 2013 Dec 20;31(36):4536-43.
 
Cheng TY, Lacroix AZ, Beresford SA, Goodman GE, Thornquist MD, Zheng Y, Chlebowski RT, Ho GY, Neuhouser ML. Vitamin D intake and lung cancer risk in the Women's Health Initiative. Am J Clin Nutr. 2013 Oct;98(4):1002-11.
 
Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Klein EA, Kristal AR. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst. 2013 Aug 7;105(15)
 
Doherty JA, Sakoda LC, Loomis MM, Barnett MJ, Julianto L, Thornquist MD, Neuhouser ML, Weiss NS, Goodman GE, Chen C. DNA repair genotype and lung cancer risk in the beta-carotene and retinol efficacy trial. Int J Mol Epidemiol Genet. 2013;4(1):11-34.
 
Cheng TY, King IB, Barnett MJ, Ambrosone CB, Thornquist MD, Goodman GE, Neuhouser ML. Serum phospholipid fatty acids, genetic variation in myeloperoxidase, and prostate cancer risk in heavy smokers: a gene-nutrient interaction in the carotene and retinol efficacy trial. Am J Epidemiol. 2013 May 15;177(10):1106-17.
 
Morgan DR, Torres J, Sexton R, Herrero R, Salazar-Martínez E, Greenberg ER, Bravo LE, Dominguez RL, Ferreccio C, Lazcano-Ponce EC, Meza-Montenegro MM, Peña EM, Peña R, Correa P, Martínez ME, Chey WD, Valdivieso M, Anderson GL, Goodman GE, Crowley JJ, Baker LH. Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. JAMA. 2013 Feb 13;309(6):578-86.
 
Pass HI, Levin SM, Harbut MR, Melamed J, Chiriboga L, Donington J, Huflejt M, Carbone M, Chia D, Goodglick L, Goodman GE, Thornquist MD, Liu G, de Perrot M, Tsao MS, Goparaju C. Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med. 2012 Oct 11;367(15):1417-27.
 
Sakoda LC, Loomis MM, Doherty JA, Julianto L, Barnett MJ, Neuhouser ML, Thornquist MD, Weiss NS, Goodman GE, Chen C. Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers. Int J Mol Epidemiol Genet. 2012;3(1):1-17.

Sakoda LC, Loomis MM, Doherty JA, Julianto L, Barnett MJ, Neuhouser ML, Thornquist MD, Weiss NS, Goodman GE, Chen C. Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers. IntJMolEpidGenet. 3(1):1-17, 28 Feb 2012.

Chu DZ, Hussey MA, Alberts DS, Meyskens FL Jr, Fenoglio-Preiser CM, Rivkin SE, Mills GM, Giguere JK, Blanke CD, Goodman GE. Colorectal Chemoprevention Pilot Study (SWOG-9041), Randomized and Placebo Controlled: The Importance of Multiple Luminal Lesions. Clin Colorectal Cancer. 10(4):310-6, Dec 2011. Epub 22 Jul 2011.

Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LH. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 306(14):1549-56, 12 Oct 2011.

Taguchi A, Politi K, Pitteri SJ, Lockwood WW, Faça VM, Kelly-Spratt K, Wong CH, Zhang Q, Chin A, Park KS, Goodman G, Gazdar AF, Sage J, Dinulescu DM, Kucherlapati R, Depinho RA, Kemp CJ, Varmus HE, Hanash SM. Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell. 20(3):289-99, 13 Sep 2011.

Cheng TY, Barnett MJ, Kristal AR, Ambrosone CB, King IB, Thornquist MD, Goodman GE, Neuhouser ML. Genetic Variation in Myeloperoxidase Modifies the Association of Serum α-Tocopherol with Aggressive Prostate Cancer among Current Smokers. J Nutr. 141(9):1731-7, Sep 2011. Epub 27 Jul 2011.

Greenberg ER, Anderson GL, Morgan DR, Torres J, Chey WD, Bravo LE, Dominguez RL, Ferreccio C, Herrero R, Lazcano-Ponce EC, Meza-Montenegro MM, Pena R, Pena EM, Salazar-Martinez E, Correa P, Martinez ME, Valdivieso M, Goodman GE, Crowley JJ, Baker LH. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet. 378 (9790):507-14, 6 Aug 2011. Epub 20 Jul 2011.

McKay JD, Truong T, Gaborieau V, Chabrier A, Chuang SC, Byrnes G, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Bucur A, Bencko V, Holcatova I, Janout V, Foretova L, Lagiou P, Trichopoulos D, Benhamou S, Bouchardy C, Ahrens W, Merletti F, Richiardi L, Talamini R, Barzan L, Kjaerheim K, Macfarlane GJ, Macfarlane TV, Simonato L, Canova C, Agudo A, Castellsagué X, Lowry R, Conway DI, McKinney PA, Healy CM, Toner ME, Znaor A, Curado MP, Koifman S, Menezes A, Wünsch-Filho V, Neto JE, Garrote LF, Boccia S, Cadoni G, Arzani D, Olshan AF, Weissler MC, Funkhouser WK, Luo J, Lubiński J, Trubicka J, Lener M, Oszutowska D, Schwartz SM, Chen C, Fish S, Doody DR, Muscat JE, Lazarus P, Gallagher CJ, Chang SC, Zhang ZF, Wei Q, Sturgis EM, Wang LE, Franceschi S, Herrero R, Kelsey KT, McClean MD, Marsit CJ, Nelson HH, Romkes M, Buch S, Nukui T, Zhong S, Lacko M, Manni JJ, Peters WH, Hung RJ, McLaughlin J, Vatten L, Njølstad I, Goodman GE, Field JK, Liloglou T, Vineis P, Clavel-Chapelon F, Palli D, Tumino R, Krogh V, Panico S, González CA, Quirós JR, Martínez C, Navarro C, Ardanaz E, Larrañaga N, Khaw KT, Key T, Bueno-de-Mesquita HB, Peeters PH, Trichopoulou A, Linseisen J, Boeing H, Hallmans G, Overvad K, Tjønneland A, Kumle M, Riboli E, Välk K, Vooder T, Metspalu A, Zelenika D, Boland A, Delepine M, Foglio M, Lechner D, Blanché H, Gut IG, Galan P, Heath S, Hashibe M, Hayes RB, Boffetta P, Lathrop M, Brennan P. A Genome-Wide Association Study of Upper Aerodigestive Tract Cancers Conducted within the INHANCE Consortium. PLoS Genet. 7(3):e1001333, Mar 2011. Epub 17 Mar 2011.

Sakoda LC, Loomis MM, Doherty JA, Neuhouser ML, Barnett MJ, Thornquist MD, Weiss NS, Goodman GE, Chen C. Chromosome 15q24-25.1 variants, diet, and lung cancer susceptibility in cigarette smokers. Cancer Causes Control. 22(3):449-61, Mar 2011. Epub ahead of print 13 Jan 2011.

Fong PY, Fesinmeyer MD, White E, Farin FM, Srinouanprachanh S, Afsharinejad Z, Mandelson MT, Brentnall TA, Barnett MJ, Goodman GE, Austin MA. Association of Diabetes Susceptibility Gene Calpain-10 with Pancreatic Cancer Among Smokers. J Gastrointest Cancer. 41(3):203-8, Sep 2010. Epub 23 Feb 2010.

Anderson GL, McIntosh M, Wu L, Barnett M, Goodman G, Thorpe JD, Bergan L, Thornquist MD, Scholler N, Kim N, O'Briant K, Drescher C, Urban N. Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study. J Natl Cancer Inst. 102(1):26-38, 6 Jan 2010. Epub 30 Dec 2009. PMCID: PMC2802285

Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, Bergen AW, Li Q, Consonni D, Pesatori AC, Wacholder S, Thun M, Diver R, Oken M, Virtamo J, Albanes D, Wang Z, Burdette L, Doheny KF, Pugh EW, Laurie C, Brennan P, Hung R, Gaborieau V, McKay JD, Lathrop M, McLaughlin J, Wang Y, Tsao MS, Spitz MR, Wang Y, Krokan H, Vatten L, Skorpen F, Ameson E, Benhamou S, Bouchard C, Metsapalu A, Vooder T, Nelis M, Valk K, Field JK, Chen C, Goodman G, Sulem P, Thorleifsson G, Rafnar T, Eisen T, Sauter W, Rosenberger A, Bickeboller H, Risch A, Chang-Claude J, Wichmann HE, Stefansson K, Houlston R, Amos CI, Fraumeni JF Jr, Savage SA, Bertazzi PA, Tucker MA, Chanock S, Caporaso NE. A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma. Am J Hum Genet. 85;1-13, 13 Nov 2009. PMCID: PMC2775843

Neuhouser ML, Barnett MJ, Kristal AR, Ambrosone CB, King IB, Thornquist MD, Goodman GE. Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev. 18(8);2202-6, Aug 2009. PMCID: PMC2733330

Fesinmeyer MD, Stanford JL, Brentnall TA, Mandelson MT, Farin FM, Srinouanprachanh S, Afsharinejad Z, Goodman GE, Barnett MJ, Austin MA. Association Between the Peroxisome Proliferators-Activated Receptor-gamma Pro 12Ala Variant and Haplotype and Pancreatic Cancer in a High-Risk Cohort of Smokers: A Pilot Study. Pancreas. 38(6);631-7, Aug 2009. Epub 11 May 2009.

Takata Y, King IB, Neuhouser ML, Schaffer S, Barnett M, Thornquist M, Peters U, Goodman GE. Association of serum phospholipids fatty acids with breast cancer risk among postmenopausal cigarette smokers. Cancer Causes Control. 20(4):497-504, May 2009. Epub Mar 3 2009. PCMID: PMC2795699

Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr.. Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 301(1):39-51, 7 Jan 2009. Epub 9 Dec 2008.

Goodman GE. Assessing Toxicity in Cancer Chemoprevention Trials: The Other Side of the Coin. Cancer Prev Res. 1(7):499-502, 1 Dec 2008. NIHMSID: 144916

Goodman GE, Alberts DS, Meyskens FL. Retinol, Vitamins, and Cancer Prevention: 25 Years of Learning and Relearning. J Clin Oncol. 26(34):5495-6, 1 Dec 2008. PMCID: PMC2661498

Hung RJ, Christiani DC, Risch A, Popanda O, Haugen A, Zienolddiny S, Benhamou S, Bouchardy C, Lan Q, Spitz MR, Wichmann HE, Lemarchand L, Vineis P, Matullo G, Kiyohara C, Zhang ZF, Pezeshki B, Harris C, Mechanic L, Seow A, Ng DP, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Caporaso N, Chen C, Duell EJ, Goodman G, Field JK, Houlston RS, Hong YC, Landi MT, Lazarus P, Muscat J, McLaughlin J, Schwartz AG, Shen H, Stucker I, Tajima K, Matsuo K, Thun M, Yang P, Wiencke J, Andrew AS, Monnier S, Boffetta P, Brennan P. International lung cancer consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev. 17(11):3081-9, Nov 2008. PMCID: PMC2756735

McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, McLaughlin J, Shepherd F, Montpetit A, Narod S, Krokan HE, Skorpen F, Elvestad MB, Vatten L, Njølstad I, Axelsson T, Chen C, Goodman G, Barnett M, Loomis MM, Lubiñski J, Matyjasik J, Lener M, Oszutowska D, Field J, Liloglou T, Xinarianos G, Cassidy A; EPIC Study, Vineis P, Clavel-Chapelon F, Palli D, Tumino R, Krogh V, Panico S, González CA, Ramón Quirós J, Martínez C, Navarro C, Ardanaz E, Larrañaga N, Kham KT, Key T, Bueno-de-Mesquita HB, Peeters PH, Trichopoulou A, Linseisen J, Boeing H, Hallmans G, Overvad K, Tjønneland A, Kumle M, Riboli E, Zelenika D, Boland A, Delepine M, Foglio M, Lechner D, Matsuda F, Blanche H, Gut I, Heath S, Lathrop M, Brennan P. Lung cancer susceptibility locus at 5p15.33. Nat Genet. 40(12):1404-6, Dec 2008. Epub 2 Nov 2008. PMCID: PMC2748187

Qiu J, Choi G, Li L, Wang H, Pitteri SJ, Pereira-Faca SR, Krasnoselsky AL, Randolph TW, Omenn GS, Edelstein C, Barnett MJ, Thornquist MD, Goodman GE, Brenner DE, Feng Z, Hanash SM. Occurrence of autoantibodies to annexin 1, 14-3-3 theta and LAMR1 in pre-diagnostic lung cancer sera. J Clin Oncol. 26(31):5060-6, Nov 1 2008. Epub Sep 15 2008. PMCID: PMC2652098


Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, Newcomb LF, Plentz RR, Gurumurthy S, Redston MS, Pitteri SJ, Pereira-Faca SR, Ireton RC, Katayama H, Glukhova V, Phanstiel D, Brenner DE, Anderson MA, Misek D, Scholler N, Urban ND, Barnett MJ, Edelstein C, Goodman GE, Thornquist MD, McIntosh MW, DePinho RA, Bardeesy N, Hanash SM. A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med. 5(6):e123, Jun 10 2008. PMCID: PMC2504036

Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Chen C, Goodman G, Field J, Liloglou T, Xinarianos G, Cassidy A, McLaughlin J, Liu G, Narod S, Krokan HE, Skorpen F, Elvestad MB, Hveem K, Vatten L, Linseisen J, Clavel-Chapelon F, Vineis P, Bueno-de-Mesquita HB, Lund E, Martinez C, Bingham S, Rasmuson T, Hainaut P, Riboli E, Ahrens W, Benhamou S, Lagiou P, Trichopoulos D, Holcatova I, Merletti F, Kjaerheim K, Agudo A, Macfarlane G, Talamini R, Simonato L, Lowry R, Conway DI, Znaor A, Healy C, Zelenika D, Boland A, Delepine M, Foglio M, Lechner D, Matsuda F, Blanche H, Gut I, Heath S, Lathrop M, Brennan P. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 452:633-7, Apr 2008.

Choi JY, Neuhouser ML, Barnett M, Hong CC, Kristal AR, Thornquist M, King IB, Goodman G, Ambrosone CB. Iron intake, oxidative stress-related genes (MnSOD and MPO), and prostate cancer risk in CARET cohort. Carcinogenesis. 29(5): 964-70, 2008. Epub 2008 Feb 22. PMCID: PMC2902382

Boger-Megiddo I, Weiss NS, Barnett MJ, Goodman GE, Chen C. V89L Polymorphism of the 5α-Reductase Type II Gene (SRD5A2), Endogenous Sex Hormones, and Prostate Cancer Risk. Cancer Epidemiol Biomarkers Prev. 17(2):286-91, Feb 2008.

Pereira-Faca SR, Kuick R, Puravs E, Zhang Q, Krasnoselsky AL, Phanstiel D, Qiu J, Misek DE, Hinderer R, Tammemagi M, Landi MT, Caporaso N, Pfeiffer R, Edelstein C, Goodman G, Barnett M, Thornquist M, Brenner D, Hanash SM. Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer. Cancer Res. 67(24):12000-6, Dec 2007.

Chien JW, Au DH, Barnett MJ, Goodman GE. Spirometry, Rapid FEV1 Decline, and Lung Cancer Among Asbestos Exposed Heavy Smokers. Journal of Chronic Obstructive Pulmonary Disease. 4:339-346, Dec 2007.

Neuhouser ML, Barnett MJ, Kristal AR, Ambrosone CB, King I, Thornquist MD, Goodman GE. (n-6) PUFA Increase and Dairy Foods Decrease Prostate Cancer Risk in Heavy Smokers. J Nutr. 137(7):1821-7, Jul 2007.

Choi JY, Neuhouser ML, Barnett M, Hudson M, Kristal AR, Thornquist M, King IB, Goodman GE, Ambrosone CB. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol Biomarkers Prev. 16(6):1115-20, Jun 2007.

Goodman GE, Thornquist MD, Edelstein C, Omenn GS. Biorepositories: Let’s Not Lose What We Have So Carefully Gathered! Cancer Epidemiol Biomarkers Prev. 15(4):599-601, Apr 2006.

Hayes DC, Secrist H, Bangur CS, Wang T, Zhang X, Harlan D, Goodman GE, Houghton RL, Persing DH, Zehentner BK. Multigene real-time PCR detection of circulating tumor cells in peripheral blood of lung cancer patients. Anticancer Res. 26(2B):1567-75, Mar-Apr 2006.

Aliyu OA, Cullen MR, Barnett MJ, Balmes JR, Cartmel B, Redlich CA, Brodkin CA, Barnhart S, Rosenstock L, Israel L, Goodman GE, Thornquist MD, Omenn GS. Evidence for excess colorectal cancer incidence among asbestos-exposed men in the Beta-Carotene and Retinol Efficacy Trial. American Journal of Epidemiology 162(9):868-78, 2005 Nov 2005.


Cartmel B, Dziura J, Cullen MR, Vegso, S, Omenn GS, Goodman GE, Redlich CA. Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET). Eur J Clin Nutr. 59(10):1173-1180, Oct. 2005.

King IB, Kristal AR, Schaffer S, Thornquist M, Goodman GE. Serum Trans-Fatty Acids are Associated with Risk of Prostate Cancer in B-Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev. 14(4) 998-992, Apr 2005.

Cullen MR, Barnett MJ, Balmes JR, Cartmel B, Redlich C, Brodkin CA, Barnhart S, Rosenstock L, Goodman GE, Hammar SP, Thornquist MD, Omenn GS. Predictors of lung cancer among asbestos-exposed men in the -carotene and retinol efficacy trial. Am J Epidemiol 161: 260-270, Feb 2005.

Goodman, GE, Thornquist MD, Balmes J, Cullen MR, Meyskens F, Omenn GS, Valanis B, Williams J. Incidence of lung cancer and cardiovascular disease in CARET: 6-years of follow-up after stopping β-carotene and retinol supplements. J Natl Cancer Inst. 96(23):1743-1750, Dec 2004.

Alfano CM, Klesges RC, Murray DM, Bowen DJ, McTiernan A, Vander Weg MW, Robinson LA, Cartmel B, Thornquist MD, Barnett M, Goodman GE, Omenn GS. Physical activity in relation to all-site and lung cancer incidence and mortality in current and former smokers. Cancer Epidemiol Biomarkers Prev. 13(12):2233-2241, Dec. 2004.

Littman AJ, Jackson LA, White E, Thornquist MD, Gaydos C, Goodman GE, Vaughan TL. Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 13:1624-1630, Oct. 2004.

Littman AJ, Jackson LA, White E, Thornquist MD, Goodman GE, Vaughan TL. Prior lung diseases and risk of lung cancer in a large prospective cohort study. Cancer Causes and Control. 15(8):819-827, Oct. 2004.

Kraemer PS, Sanchez CA, Goodman GE, Jett J, Rabinovitch PS, Reid BJ. Flow cytometric enrichment for respiratory epithelial cells in sputum. Cytometry. Part A 60A 1-7, 2004

Chen C, Weiss NS, Stanczyk S, Lewis K, Dante D, Etzioni R, Barnett M, Goodman GE. Endogenous sex hormones and prostate cancer risk: A case-contgrol study nested within the Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev. 12:1410-1416, 2003.

Goodman GE, Schaffer MS, Omenn GS, Chen C, King I, CARET Co-Investigators. The association between lung and prostate cancer risk and serum micronutrients: Results and lessons learned from B-Carotene and Retinol Efficacy Trial. Cancer Epidemiology, Biomarkers & Prevention. 12:518-526, 2003.

Lamharzi N, Johnson, M, Goodman GE, Etzioni R, Weiss NS, Dightman DA, Barnett M, DiTommaso D, Chen C. Polymorphic markers in the 5-reductase type II gene and the incidence of prostate cancer. International Journal of Cancer. 105:480-483, 2003.

Neuhouser ML, Patterson RE, Thornquist MD, Omenn GS, King IB, Goodman GE. Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET). Cancer Epidem, Biom & Prev. 12:350-358, 2003.

Bowen DJ, Thornquist M, Anderson K, Barnett M, Powell C, Goodman G, Omenn G Stopping the active intervention: CARET. Controlled Clinical Trials. 24:39-50, 2003.

Spitz, MR, Barnett M, Goodman GE, Thornquist MD, Wu X, Pollak M. Serum IGF-1 and binding protein levels and risk of lung cancer: a case-control study nested in the CARET cohort. Cancer Epidemiology, Biomarkers & Prevention. 11:1413-1418, 2002.

Goodman GE. Lung Cancer – 1 Prevention. Thorax 57:994-999, 2002.

Chen C, Lamharzi N, Weiss NS, Etzioni R, Dightman DA, Barnett M, DiTommaso D, Goodman G. Androgen receptor polymorphisms and the incidence of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention 11:1033-1040, 2002.

Thornquist M, Edelstein C, Goodman GE, Omenn GS. Streamlining IRB review in multisite trials through single-study IRB Cooperative Agreements: experience of the -Carotene and Retinol Efficacy Trial (CARET). Cont Clin Trials 23:80-86, 2002.

Ellis WJ, Etzioni R, Vessella RL, Goodman GE. Serial prostate specific antigen, free/total PSA ration, and complexed PSA in the diagnosis of prostate cancer. Jnl of Urology 166:93-98, 2001.

Goodman G, Schaffer S, Bankson DD, Hughes MP, Omenn GS, CARET Co-Investgators. Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk. Cancer Epid., Biom. & Prev 10:1069-1076, 2001.

Hellstrom I, Ledbetter JA, Scholler N, Yang Y, Ye Z, Goodman G, Pullman J, Hayden-Ledbetter M, Hellstrom KE. CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer. Proc. Natl. Acad Sci USA 2001 Jun 5;98(12):6783-8.

Lippman SM, Lee JJ, Karp DD, Vokes EE, Benner SE, Goodman GE, Khuri FR, Marks R, Winn RJ, Fry W, et al. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. Journal of National Cancer Institute 93(8):605-618; April 2001.

Goodman GE. Prevention of lung cancer. Critical Reviews in Oncology/Hematology. 33:187-197, 2000.

Bowen D, Thornquist M, Anderson K, Barnett M, Goodman G, Valanis B, Omenn G. Effects of incentive items on participation in a randomized chemoprevention trial. Jnl of Health Psych 5(1) 109-115; 2000.

Scholler N, Fu N, Yang Yi, Zhengmao Y, Goodman GE, Hellstrom K, Hellstrom I. Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proc Natl Acad Sci 96:11531-11536, 1999.

Bowen D, Cartmel B, Barnett M, Goodman G, Omenn G. Predictors of retention in two chemoprevention trials. Annals of Behav Med 21(3):210-215, 1999.

Greenwald HP, Polissar NL, Borgatta EF, McCorkle R, Goodman G. Social factors, treatment, and survival in early-stage non-small cell lung cancer. Am Jnl Pub Health. 88(11):1681-1684; November 1998.

Goodman G, Valanis B, Meyskens F, Williams J, Metch B, Thornquist M, Omenn G. Strategies for recruitment to a population-based lung cancer prevention trial: the CARET experience with heavy smokers. Cancer Epidemiology, Biomarkers & Prevention 7:405-412, 1998.

Goodman GE. Prevention of lung cancer. Current Opinion in Oncology 10:122-126, March 1998.

Barnhart S, Keogh J, Cullen MR, Brodkin C, Liu D, Goodman G, Valanis B, Glass A, Thornquist M, Rosenstock L, Omenn G, Balmes J. The CARET Asbestos-Esposed Cohort: Baseline Characteristics and Comparison to Other Asbestos-Exposed Cohorts, Am Journ Indust Med, 32:573-581, 1997.

Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH, Barnhart S, Cherniack MG, Brodkin CA, Hammar S. Risk Factors for Lung Cancer and for Intervention Effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. Journal of National Cancer Institute, 88 (21): 1550-1559, 1996.

Goodman GE, Thornquist M, Kestin M, Metch B, Anderson G, Omenn GS, and CARET Coinvestigators. The Association between Participant Characteristics and Serum Concentrations of Beta-Carotene, Retinol, Retinyl Palmitate, and alpha-Tocopherol among Participants in the Carotene and Retinol Efficacy Trial (CARET) for Prevention of Lung Cancer. Cancer Epidemiology, Biomarkers & Prevention, Vol 5, 815-821, October 1996.

Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine, Vol. 334, 1150-1155, May 2, 1996.

Omenn GS, Goodman GE, Thornquist M, Brunzell JD. Long-Term Vitamin A Does not Produce Clinically Significant Hypertriglyceridemia: Results from CARET, the Beta Carotene and Retinol Efficacy Trial. Cancer Epidemiology, Biomarkers and prevention, Vol. 3, 711-713, December 1994.

Omenn GS, Goodman GE, Thornuist M, Grizzle J, Rosenstock L, Barnhart S, Balmes J, Cherniack M, Cullen M, Glass A, Keogh J, Meyskens F, Valanis B, Williams J. The B-carotene and Retinol Efficacy Trial (CARET) for chemoprevention of lung cancer in high-risk populations: smokers and asbestos-exposed workers. Cancer Res 54:2038S-2043, 1994.

Goodman GE, Metch BJ, Omenn GS. The Effect of Long-Term Beta-Carotene and Vitamin A Administration of Serum Concentrations of Alpha-Tocopherol. Cancer, Epidemiology, Biomarkers and Prevention, Vol 3, 429-432, July/August 1994.

Bukowski RM, Young J, Goodman G, Meyers F, Issell BF, Sergi JS, McLain D, Fyfe G, Finke J. Polyethylene glycol conjugated interleukin-2: Clinical and immunologic effects in patients with advanced renal cell carcinoma. Investigational New Drugs 11:211-217, 1993.

Thornquist MD, Omenn GS, Goodman GE, Grizzle JE, Rosenstock L, Barnhart S, Anderson GL, Hammar S, Balmes J, Cherniack M, Cone J, Cullen MR, Glass A, Keogh JP, Meyskens F, Valanis B, Williams JH. Statistical Design and Monitoring of the Carotene and Retinol Efficacy Trial (CARET). Controlled Clinical Trials 14:308-324, 1993.

Goodman GE. Cancer prevention: Chemoprevention vs dietary modifications. Preventive Medicine 22: 689-692, 1993.

Goodman GE. The prevention of primary lung cancer. In: Lung Cancer. Current Clinical Oncology Series, 1993.

Omenn GS, Goodman GE, Thornquist MD, Rosenstock L, Barnhart S, Gylys-Colwell I, Metch B, Lund B. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high risk populations: pilot study with asbestos-exposed workers. Cancer Epidemiol Biomarkers and Prev, 2:381-387, July/August 1993.

Goodman GE, Omenn GS, Thornquist MD, Lund B, Metch B, Gylys-Colwell I. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high risk populations: pilot study with cigarette smokers. Cancer Epidemiol Biomarkers and Prev, 2:389-396, July/August 1993.

Goodman GE, Hellstrom I, Yelton DE, Murray JL, O'Hara S, Meaker E, Zeigler L, Palazollo P, Nicaise C, Usakewicz J, Hellstrom KE. Phase I trial of chimeric (human mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer. Cancer Immunol Immunother, 36:267-273, 1993.

Goodman GE. Chemoprophylaxis Strategies in High Risk Groups with an Emphasis on Lung Cancer. Chest, 103:60s-62s, 1993.

Goodman GE. The clinical evaluation of cancer chemoprevention agents: defining and contrasting phase I, II, and III objectives. Cancer Res Suppl. 52:2752s-2757s, 1993.

Goodman GE, Omenn GS, and CARET Coinvestigators and Staff. Carotene and Retinol Efficacy Trial: Lung Cancer Chemoprevention Trial in Heavy Cigarette Smokers and Asbestos-exposed Workers. Adv Exp Med Biol 320:137-140, 1992.

Konrad MW, DeWitt SK, Badley EC, Goodman G, Groes EC, Hersh EM, Krigel RL, and Rudolph A. Interferon-y Induced by Administration of Recombinant Interleukin-2 to Patients with Cancer: Kinetics, Dose Dependence, and Correlation with Physiological and Therapeutic Response. J Immunol 12:55-63, 1992.

Goodman GE, Omenn GS. Lung cancer chemoprevention in heavy cigarette smokers and asbestos-exposed workers. The Cancer Bulletin: 43:534-537, 1991.

Goodman GE, Crowley J, Livingston RB, Rivkin SE, Albain K, and McCulloch JH. Treatment of Limited Small-Cell Lung Cancer with Concurrent Etoposide/Cisplatin and Radiotherapy Followed by Intensification with High Dose Cyclophosphamide; A Southwest Oncology Group Study. J Clin Onc: 453-457, 1991.

Barnhart S, Thornquist M, Omenn GS, Goodman GE, Feigl P, Rosenstock L: The Degree of Roentgenographic Parenchymal Opacities Attributable to Smoking Among Asbestos-Exposed Subjects. Am Rev Respir Dis 141: 1102-1106, 1990.

Mortimer JE, Schulman S, MacDonald JS, Kopecky K, Goodman GE: High Dose Cisplatin in Disseminated Melanoma: A Comparison of Two Schedules. Cancer Chemo Pharm 25:373-376, 1990.

Goodman GE, Crowley JJ, Blasko JC, Livingston RB, Beck RM, Dernatia MD, Bukowski RM: Treatment of Limited Small Cell Lung Cancer with Etoposide and Cisplatin Alternating with Vincristine, Doxorubicin and Cyclophosphamide Versus Concurrent Etoposide, Vincristine, Doxorubicin and Cyclophosphamide and Chest Radiotherapy: A Southwest Oncology Group Study. J Clin Onc 8(1):39-47, January 1990.

Goodman GE, Hellstrom I, Brodzisky L, Nicaise C, Kulander B, Hummell D, Hellstrom KE. Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancer. J Clin Oncol. 8:1083-1092, 1990.

Goodman GE, Livingston RB: Small Cell Lung Cancer. Disease-A-Month. Year Book Medical Publishers, Inc. Volume XXXV. December 1989.

Goodman GE, Livingston RB: Small Cell Lung Cancer. Current Problems in Cancer. Year Book Medical Publishers, Inc. Volume XIII, January/February 1989.

Omenn GS, Goodman GE, Kleinman GD, Rosenstock L, Barnhart S, Feigl P, et al. The role of intervention studies in ascertaining the contribution of dietary factors in lung cancer: The Seattle chemoprevention trial of retinoids in asbestos exposed workers. Ann NY Acad Sci, 534:575-583, 1988.

Kalman DA, Goodman GE, Omenn GS, Garland B, Rollins B: Micronutrient Assay for Cancer Prevention Clinical Trials: Serum Retinol, Retinyl Palmitate, Alpha-Carotene and Beta-Carotene Using High Performance Liquid Chromatography. J Clin Onc 79(5):975-982, November 1987.

Goodman GE, Yen YP, Cox T, Crowley J: The Effect of Verapamil on In Vitro Cytotoxicity of Adriamycin and Vinblastine. Cancer Research, 47:2295-2304, May 1, 1987.

Goodman GE, Christofferson E, Kaplan HG, Rivkin SE, Wasserman P, Weber EL and PSOC: Phase II Trial of Retinol in Patients with Advanced Cancer. Can Treat Rep 70(8)1023-1024, August 1986.

Prentice RL, Omenn GS, Goodman GE, Chu J, Henderson MM, Feigl P, et al. Rationale and design of cancer chemoprevention studies in Seattle. NCI Monograph 69:249-258, 1985.

Goodman GE, Beaumier P, Hellstrom I, Fernyhough B, Hellstrom KE: Pilot Trial of Murine Monoclonal Antibodies in Patients with Advanced Melanoma: J Clin Onc 3:340-352, 1985.

Goodman GE: Modulation of IN Vitro Activity of Adriamycin and Vinblastine by Verapamil. Human Tumor Cloning, Eds. SE Salmon and JM Trent, 389-394, 1984.

Villar, Hugo, Jones, Stephen E, Goodman GE, Grogan TM, Pond GD, and Wangensteen SL: Post Treatment Laparotomy for Hodgkin's Disease. Arch Surg 118:1272-1276, 1983.

Goodman GE, Miller TP, Manning MM, Davis SL, McMahon LJ: Treatment of Small Cell Lung Cancers with VP-16/Vincristine/Adriamycin/Cyclo-phosphamide (EVAC) and High-Dose Radiotherapy. J Clin Onc 1:483-488, 1983.

Goodman GE, Alberts DS, Ernest DL and Meyskens FL: Phase I Trial of Retinol in Cancer Patients. J Clin Onc 1:394-399, 1983.

Goodman GE, Alberts DS, Peng YM, Beaudry J, Leigh SA and Miles NJ: Plasma Kinetics of Oral Retinol in Cancer Patients. Cancer Treat Rep 68:1125-1133, 1984.

Goodman GE, Jones SE, Villar HV, Silverstein ME, Dubich L and Newcomb SR: Surgical Restaging of Hodgkin's Disease. Cancer Treat Rep 66:751-757, 1982.

Davis TP, Peng YM, Goodman GE and Alberts DS: High Performance liquid chromatography, Mass Spectrometry and Pharmacokinetics of Melphalan, Bisantrene and 13-Cis-Retinoic Acid. J Chrom Sci 20:511-516, 1982.

Goodman GE, McLean A, Alberts DS, Chang SY: Inhibition of Human Tumor Clonogenicity by Chlorambucil and its Metabolites. Br J Cancer 45:521-523, 1982.

Goodman GE, Einspahr JG, Alberts DS, Davis TP, Leigh SA, Chen HSG and Meyskens FL: Pharmacokinetics of 13-cis-Retinoic Acid in Patients with Advanced Cancer. Cancer Research 42:2087-1091, 1982.

Goodman GE, Manning MR, Ketchel S, Jackson R and McMahon LJ: Improved Survival in Small Cell Lung Cancer Treated with Combination Chemotherapy (EVAC) and High Dose Adjuvant Radiotherapy (XRT). Adjuvant Therapy of Cancer III, Eds. SE Salmon and SE Jones, Grune & Stratton, 277-288, 1981.

Alberts DS, Griffith DS, Goodman GE, Herman TS and Murray E: Phase I Clinical Trial of Mitoxantrone: A New Anthracenedione Drug Cancer. Chemother Pharmacol 5/1980:11-15.

Goodman GE: Thrombotic Thrombocytopenia Purpura "State of the Art". Arizona Medicine, 180-183, March 1980.
________________________________________

BOOK CHAPTERS:

Goodman, GE. The Clinical Evaluation of Cancer Prevention Agents. PSEBM, Vol 216, 253-259, 1997

Goodman GE. Cancer Prevention: Contrasting Dietary Modification with Intervention Agents. Encyclopedia of Cancer. eds. Joseph R. Bertino, Academic Press, Vol 1: 199-206, 1997.

Omenn GS, Goodman G, Thornquist M, Barnhart S, Balmes J, Cherniack M, Cullen M, Glass A, Keogh J, Liu D, Meyskens Jr F, Perloff M, Valanis B, Williams Jr J. Chemmoprevention of lung cancer: the B-Carotene and Retinol Efficacy Trial (CARET) in high risk smokers and asbestos-exposed workers. Chemoprevention in Cancer Control, eds. M Hakama, V Beral, E Buiatti, J Faivre adn DM Parkin. IARC Scientific Publications No. 136. International Agency for Research on Cancer, Lyon, 1996.

Goodman GE. The Prevention of Primary Lung Cancer. Lung Cancer, Eds. BE Johnson and DH Johnson. Wiley-Liss, Inc. 1995.

Goodman GE, Omenn GS, CARET Co-Investigators and Staff. Carotene and Retinol Efficacy Trial: Lung Cancer Chemoprevention Trial in Heavy Cigarette Smokers and Asbestos-exposed Workers. The Biology and Prevention of Aerodigestive Tract Cancers, Eds. GR Newell and WK Hong. 1992.

Goodman GE, Omenn GS, Feigl P, Kleinman GD, Lund B, Thomas DB, Henderson MM, Prentice R: Chemoprevention of Lung Cancer with Retinoids/Beta-Carotene. In 2nd International Conference on the Modulation and Mediation of Cancer by Vitamins. Eds. FL Meyskens and K Prasad. 1985. pp. 341-350.

Meyskens FL, Goodman GE, Alberts DS: 13-Cis-Retinoic Acid: Pharmacology, Toxicology and Clinical Applications for the Prevention and Treatment of Human Cancer. CRC Critical Reviews in Oncology/Hematology, Vol 3:75-101, Issue 1.

Hellstrom KE, Hellstrom I, Goodman GE and Brankovan V: Antibody Dependent Cellular Cytotoxicity to Human Melanoma Antigens in: Monoclonal Antibodies and Cancer Therapy. Series UCLA symposium on monoclonal and cellular biology. New series V. 27, Eds. RA Reisfeld, S Sell. Pubs. Alan R. Liss Inc., N.Y., N.Y., 1985.

________________________________________

ABSTRACTS:

Ferreccio C, Anderson GL, Morgan D, Torres J, Bravo LE, Dominguez R, Herrero R, Meza-Montenegro M, Pena R, Salazar-Martinez E, Chey WD, Valdivieso M, Crowley J, Goodman GE, Greenberg ER, Baker LH. A randomized trial comparing 14-day triple, 10-day sequential, and 5-day concomitant therapy to eradicate Helicobacter pylori in seven Latin American populations. Disease Digestive Week, Chicago, Illinois, May 2011.

Thornquist M, Barnett M, Reid S, Edelstein C, Warnick G, Lin P, Goodman G. Tracking, Annotating, And Advertising Biorepository Specimens: The Carotene and Retinol Efficacy Trial (CARET) as a Benchmark. Biospecimen Research Network Symposium, Bethesda, Maryland, March 2009.

Goodman G, Barnett M, Edelstein C, Thornquist M. An Overview of the Carotene and Retinol Efficacy Trial (CARET) and Biorepository. Canary Symposium, Stanford, California, May 2008.

Goodman G, Barnett M, Edelstein C, Thornquist M. An Overview of the Carotene and Retinol Efficacy Trial (CARET), a COMPASS multi-site study. Canary Symposium, Stanford, California, May 2007.

Littman AJ, Thornquist MD, Jackson LA, White E, Goodman GE, Vaughan TL. Previous lung disease and risk of lung cancer in a large prosective cohort study. American College of Epidemiology, 2003.

Chen C, Lamharzi N, Weiss N, Etzioni R, , Dightman D, Barnett M, DiTommaso D, Goodman G. Polymorphic markers in the SRD5A2 gene and androgen receptor gene and the risk of prostate cancer. American Association for Cancer Research (AACR), 2002.

Neuhouser ML, Patterson RE, Thornquist MD, King IB, Goodman GE. Fruits and vegetables from the cruciferae, rutaceae and rosaceae families decrease lung cancer risk among heavy smokers and asbestos exposed workers. American Society of Preventive Oncology (ASPO), 2002.

Goodman, GE. Supplemental Beta-Carotene as a Cancer Prevention Agent. Workshop on Dietary Antioxidants and Related Compounds , Institute of Medicine, National Academy of Sciences, 1998.

King IB, Thornquist M, Omenn GS, Goodman GE. Prediagnostic serum fatty acids and risk of prostate cancer in CARET (Carotene and Retinol Efficacy Trial). Federation of American Society for Experimental Biology (FASEB), 1998.

SM Lippman, JJ Lee, DD Karp, EE Vokes, SE Benner, GE Goodman, C Kardinal, RJ Winn, JA Roth, WK Hong. UT MD Anderson Cancer Center (MDACC)-Houston, TX; ECOG-Brookline, MA; CALGB-Chicago, IL; RTOG -Philidelphia, PA; SWOG-San Antonio, TX; NCCTG-Rochester, MN; MDACC CCOP-Houston, TX. Phase III Intergroup Trial of 13-CIS-Retinoic Acid to Prevent Second Primary Tumors in Stage I Non-Small Cell Lung Cancer (NSCLC): Interim Report of NCI #I91-0001; ASCO 1997

Goodman GE, Omenn GS, Thornquist M. CARET: the beta-Carotene and Retinol Efficacy Trial for the chemoprevention of lung cancer in high risk population. ASCO, May 1996.

Williams J, Meyskens F, DeJohn J, Zolkower J, Thornquist M, Omenn GS, Goodman GE, Metch B, Valanis B, Goass A, Balmes J, Keogh J, Cullen M. Retention in ongoing CARET cancer prevention study is affected by related study reports. ASPO 1995.

Goodman, GE: Retinoid and Carotenoid Chemoprevention Trials. AACC, 1994.

Goodman GE, Gylys-Colwell I, Anderson G, Kestin M, Omenn G, CARET Co-investigators. Association between food frequency questionnaire estimates and serum concentrations of beta-carotene, retinol, retinyl palmitate, and alpha-tocopherol among participants in the CARET lung cancer chemoprevention trial. Society for Clinical Trials, 1994.

Goodman GE, Omenn GS, Lund B, Thornquist M, Metch B, Gylys-Colwell I. Long term evaluation of side effects of beta-carotene and retinol: smoker’s pilot to the Carotene and Retinol Efficacy Trial (CARET), ASPO, 1993.

Goodman GE, Hellstrom I, Stevenson U, Steen K, Hellstrom KE: Phase I Trial of Murine Monoclonal Antibody MG-22 and IL-2 in Patients with Disseminated Melanoma. ASCO, 1992.

Maguire YP, Garrison L, Lieu KL, Seigneuret M, Kuzan F, Drabek S, Goodman GE, Von Hoff D, Bartels P: Growth of Human Tumors on Extracellular Matrix and 1% Serum Supplemented Medium. AACR, 1992.

Goodman GE, CARET Co-Investigators and Staff: Recruitment to Chemoprevention Trials: The CARET Experience. ASPO, 1991.

Hellstrom KE, Goodman GE, Hellstrom I: Unmodified Antibodies for Cancer Therapy. 15th International Cancer Congress. August, 1990.

Goodman GE, Omenn GS: Seattle Lung Cancer Chemoprevention Trial: Caret Beta-Carotene and Retinol Efficacy Trial. ASCO, 1990.

Goodman GE, Murray JL, Hellstrom KE, Nicaise C, Yelton D, Palazollo P, Ziegler L, Hellstrom I: Phase I Trial of Chimeric Monoclonal Antibody L6 (chL6). AACR, 1990.
Goodman GE, Smith MR, Peters W, Latteier J: Treatment of Relapsing Ovarian Cancer with VP-16, Cis-platinum and Continuous Infusion of 5-FU. AACR, 1989.

Goodman GE, Blasko JC, Livingston RB: Treatment of Small Cell Lung Cancer with Concurrent VP-16/CDDP and Chest Radiotherapy, Followed by Intensification with High Dose Cyclophosphamide. SWOG 8573. ASCO, 1989.

Omenn GS, Goodman GE, Rosenstock L, Barnhart S, Feigl P, Thornquist M: Chemoprevention of Lung Cancer with Beta-Carotene and Retinol in Persons at High Risk Due to Asbestos Occupational Exposures and/or Cigarette Smoking, A Double-Blind Randomized Trial. International Symposium, Biological Interaction of Inhaled Mineral Fibers and Cigarette Smoke. April 1988.

Goodman GE, Hummel D, Berman J, Groves E: Phase I/II Trial of Continuous Infusion (CI) of Recombinant Human IL2 in Patients with Melanoma and Renal Cell Carcinoma. ASCO, 1988.

Goodman GE, Hellstrom I, Brodzinsky L, Hummel D, Berman J, Smaldone L, Hellstrom KE: Phase I Trial of Murine Monoclonal Antibody (MAb) L6 Directed Against a Surface Antigen Expressed in Human Lung, Colon, Ovary and Breast Cancer. AACR, 1988.

Barnhart S, Rosenstock L, Feigl P, Thornquist M, Goodman GE and Omenn G: Smoking Behavior Among as Asbestos-Exposed Cohort Does Not Predict Prevalence of Fibrosis But Does Enhance Its Extent. American Thoracici Society, 1987.

Yeh MY, Yu DS, Hellstrom I, Goodman GE and Hellstrom KE: Mouse Monoclonal Anti-Idiotypic Antibody to MG-21, a Mouse IgG3 Monoclonal Antibody to a Human Melanoma-Associated GD3 Ganglioside Antigen. AACR, 1987.

Goodman GE, Hellstrom I, Hummel D, Brodzinsky L, Yeh MY, Hellstrom KE: Phase I Trial of Monoclonal Antibody MG-21 Directed Against a Melanoma Associated GD3 Ganglioside Antigen. ASCO, 1987.

Omenn GS, Goodman GE, Rosenstock L, Barnhard S, Lund B, Kleinman G, Feigl P: Chemoprevention of Lung Cancer in Asbestos-Exposed Men. Prevention, 1987.

Goodman GE and Blasko J:Concurrent Chemotherapy with VP-16/Vincristine/Adriamycin/Cyclophosphamide (EVAC)Versus Alternating Chemotherapy with VP-16/Cis-platinum and Vincristine/ Adriamycin/Cyclophosphamide (VPP/VAC) in Limited Small Cell Lung Cancer (SCLC): A Southwest Oncology Group Study (SWOG). ASCO, 1986.

Goodman GE, Yen YP, Cox TC: Malignant Effusion Stimulates the Cloning of Fresh Human Tumors in Soft Agar. AACR, 1986.

Kaplan HG, Yen YP, Cox T, Goodman GE: Rapid Chemosensitivity Assay Based on 3H-Thymidine Incorporation of Fresh Human Tumors. AACR, 1986.

Goodman GE, Omenn GS, Feigl P, Kleinman GD, Lund B, Thomas DB, Henderson MM, Prentice R: Chemotherapy of Lung Cancer with Retinoids/Beta-Carotene. 2nd International Conference on the Modulation and Medication of Cancer by Vitamins, 1985.

Goodman GE, Christofferson E, Kaplan HG, Rivkin SE, Wasserman P, Weber EL and PSOC. A Phase II Trial of Retinol in Cancer Patients. ASCO, 1985.

Yen YP, Diwan M, Kaplan HG, Crowley J, Goodman GE: The Effect of Verapamil on In Vitro Cytotoxicity of Adriamycin and Vinblastine. AACR, 1985.

Hellstrom KE, Brandovan V, Goodman GE, Hellstrom I: IgG3 Antibodies to a Human Melanoma-Associated Ganglioside Antigen with Strong Anti-tumor Activities. UCLA Symposium, February 1985.

Goodman GE, Omenn GS, Feigl P, Kleinman GD, Lund B, Thomas DB, Henderson MM, Prentice R: Chemoprevention of Lung Cancer with Retinoids/Beta-Carotene. 2nd International Conference on the Modulation and Mediation of Cancer by Vitamins, 1984.

Goodman GE, Armi Salo and Diwan M: Lack of In Vitro Synergism of Verapamil with Adriamycin and Vinblastine. 4th International Conference on Human Tumor Cloning, Tucson, Arizona. January 8-10, 1984.

Goodman GE, Baumier P, Hellstrom I and Hellstrom KE: Phase I Trial of Two Murine Monoclonal Antibodies (MAb) in Human Melanoma. ASCO, Toronto, May 1984.

Villar HV, Goodman GE and Jones SE: Post-Treatment Laparotomy (Restaging Laparotomy for Hodgkin's Disease). Southwest Surgical Congress, 1982.

Goodman GE, Alberts DS, Meyskens F, Peng YM, Beaudry J, Leigh S and Chang SY: Pharmacokinetics and Phase I Clinical Trial of Retinol (R) in Cancer Patients. AACR 23:129, 1982.

Goodman GE and Jones SE: Surgical Restaging of Hodgkin's Disease. Contemporary Issues in Hodgkin's Disease, Biology, Staging and Treatment. NCI and CCIRC Symposium, San Francisco, California, 1981.

Goodman GE, McMahon LJ, Manning MR and Salmon SE: Treatment of Small Cell Lung Cancer with VP-16/Vincristine/Adriamycin/Cyclophosphamide (EVAC), and High Dose Radiation (XRT). ASCO 22:495, 1981.

Goodman GE, Eispahr JG, Leigh SA, Alberts DS, Chen HSG, Davis TP, Meyskens FL, Chang SY: High Performance Liquid Chromatographic Analysis and Human Pharmacokinetics of 13-Cis-Retinoic Acid. AACR 22:212, 1981.

Goodman GE, Chang SY and Alberts DS: The Anti-tumor Activity of Melphalan and Its Hydrolysis Products. ASCO 21:301, 1980.

Goodman GE, Schulmann MP and Radulovacki M: 5HIAA and 5HTOH in Cisternal CSF after Acute Ethanol Administration. American Physiologic Society for Sleep, Grand Teton, Colorado, 1974.

Goodman GE and Radulovacki M: 5HIAA in Successive Samples of CSF from the Cisterna Magna in Cats. 5th International Congress in Pharmacology. San Francisco, California, 1972.
________________________________________

EDITORIALS:

Goodman, GE. Review of Benner/Lippman/Hong Article, Retinoid Chemoprevention of Lung Cancer. Oncology, April 1995.

Offices

Medical Oncology / First Hill - Swedish Cancer Institute
1221 Madison Street
Arnold Pavilion, Suite 200
Seattle, WA 98104
Phone: 1-(855)-XCANCER (1-855-9226237) or (206) 215-3600

Map & Directions

Swedish Cancer Institute-Medical Oncology
1221 Madison Street
2nd Floor
Seattle, WA 98104
Phone: (206) 386-2122
Fax: (206) 215-3962

Map & Directions

Physicians: Is this your profile? Click here for info